Manage spend, access essential drugs and improve quality outcomes
Your pharmacy’s impact reaches almost every area of your organization—getting critical drugs to patients, providing expert staff when needed, ensuring regulatory compliance, and so much more. Members depend on Vizient’s data-driven insights to help achieve cost efficiencies, performance gains, and clinical improvements. From inpatient to outpatient care, we deliver solutions that optimize your pharmacy for high-quality patient care and financial growth.
contracted products, including generics, brand, biosimilars, plasma, radiopharmaceuticals
Access essential medications
We are dedicated to developing solutions to resolve drug shortages. From our essential medications list to our Novaplus programs, we offer resources that deliver additional inventory of essential medications and products.
This program delivers additional inventory of essential medications that are critical to your clinicians' ability to provide immediate and high-quality patient care. Under the program, suppliers provide additional inventory of essential products to mitigate supply disruptions and demand surge. The program improves supply chain resiliency and helps end product shortages via transparency, accountability and commitment to supply.
For many patients with cancer in the U.S., the generic injectable medications preferred for treatment may not currently be available. This challenge is in part due to a national shortage of various oncology medications.
-Vizient report, August 2023
Reduce drug spend
Our contract portfolio sets your pharmacy up to be a strategic business asset and competitive advantage. Offerings include brand, generics, plasma, specialty, biosimilar, contrast and radiopharmaceutical products.
Novaplus, the Vizient private-label, delivers additional financial value, quality and support on pharmaceuticals, medical-surgical products, and purchased services offerings. Many of the nation’s leading healthcare systems rely on Novaplus for consistent access, market-competitive pricing and on-going value for almost 50% of the drugs considered in short supply today. On average, Novaplus pharmaceutical products offer a 20 percent total value for Vizient members.
Pharmacy leaders must effectively manage pharmacy costs while also optimizing quality of care, leveraging data with clinical evidence to drive decisions, and implementing utilization improvement strategies. The Vizient Pharmacy Network Program Aggregation Groups program represents more than $40B annual pharmacy spend and $359M in member value and empowers members to:
- Collaborate with peers real-time in a safe, trusted environment
- Access Vizient executive peer resources to stay on the forefront of key trends
- Use robust data analytics, summaries and reports for opportunity identification
RxCommit is a sourcing solution for Vizient members who are ready to standardize their formulary preference in specific categories to get volume contract savings.The program is appropriate for a continuum ranging from small, rural and independently controlled members to large integrated delivery networks and academic medical centers, including acute and non-acute care. RxCommit staff works with members to facilitate communication.
Biosimilars savings in the U.S. from 2014-2022
Improve clinical and operational insights
Vizient uses data-driven insights to help members achieve impressive cost efficiencies, performance gains, and clinical improvements. We provide expertise and performance improvement across a variety of areas, including pharmacy operations, clinical and outpatient, and 340B Program consulting.
Drug costs are a significant and growing expense for health systems. Transparency into reliable pharmacy analytics is critical to making informed decisions in order to level prices and improve accessibility and utilization. With real-time visibility into expense management across all care settings, organizations rely on Vizient Pharmacy Analytics to redefine pharmacy as a strategic contributor in a hospital’s ability to reduce pharmaceutical spend while improving outcomes.
The Vizient Center for Pharmacy Practice Excellence monitors, informs, connects and advocates for Vizient members by applying clinical and operational knowledge on pharmaceutical market developments and key policy changes that impact access to therapy, drug spend, patient outcomes and market performance. In 2021 a total of about 2,800 continuing education credits were received by members via webinars provided by the Vizient Center for Pharmacy Practice Excellence. Tandem offerings include the VerifiedRx monthly podcast, CE webinars on clinical pharmacy topics and more.
Projected drug price inflation rate
Drive organizational performance in non-acute care
Vizient offers ambulatory and specialty pharmacy consulting solutions that provide customized business plan development, implementation, and accreditation support for a fully integrated, patient-focused solutions.
This network brings together health system oncology practices and clinics to drive savings and achieve high-quality patient outcomes. Members receive the following benefits:
- Participation in the nation’s largest member-driven Oncology Network
- Access to cost-savings initiatives with proven results and better clinical outcomes
- Collaboration with like-minded oncology systems seeking common endpoints
- Sharing pharmacy oncology best practices through discussion and in-person/on-site rotating meetings
Pharmaceuticals have exponentially advanced with new infusion drugs available to treat disease states, many of which can be administered in ambulatory environments.
Vizient Sites of Infusion Care report
per year. Annualized financial impact of white bagging
per year. Annual cost of labor needed to manage drug shortages
Inventory cost avoidance through Novaplus Enhanced Supply
Vizient solutions help you to stabilize and manage spend today, access the critical drugs to deliver quality care and support pharmacy’s contribution to success.
Connect with pharmacy leaders
and engage with your peers to stay at the forefront of trends
Aggregate to save
through collaboration and evidence-based leading practices
through our programs that provide access to additional inventory of essential medications
Optimize financial impact
through our customized business plan development and implementation
Improve patient care and outcomes
with our real-time data and transparency
Leverage our expertise
to fortify the supply chain, improve access and deliver cost savings